ABSTRACT
Obesity promotes the development of numerous cancers, such as liver and colorectal cancers, which is at least partly due to obesity-induced, chronic, low-grade inflammation. In particular, the recruitment and activation of immune cell subsets in the white adipose tissue systemically increase proinflammatory cytokines, such as tumor necrosis factor α (TNFα) and interleukin-6 (IL-6). These proinflammatory cytokines not only impair insulin action in metabolic tissues, but also favor cancer development. Here, we review the current state of knowledge on how obesity affects inflammatory TNFα and IL-6 signaling in hepatocellular carcinoma and colorectal cancers.
ABSTRACT
Colorectal cancer (CRC) is one of the most lethal cancers worldwide in which the vast majority of cases exhibit little genetic risk but are associated with a sedentary lifestyle and obesity. Although the mechanisms underlying CRC and colitis-associated colorectal cancer (CAC) remain unclear, we hypothesised that obesity-induced inflammation predisposes to CAC development. Here, we show that diet-induced obesity accelerates chemically-induced CAC in mice via increased inflammation and immune cell recruitment. Obesity-induced interleukin-6 (IL-6) shifts macrophage polarisation towards tumour-promoting macrophages that produce the chemokine CC-chemokine-ligand-20 (CCL-20) in the CAC microenvironment. CCL-20 promotes CAC progression by recruiting CC-chemokine-receptor-6 (CCR-6)-expressing B cells and γδ T cells via chemotaxis. Compromised cell recruitment as well as inhibition of B and γδ T cells protects against CAC progression. Collectively, our data reveal a function for IL-6 in the CAC microenvironment via lymphocyte recruitment through the CCL-20/CCR-6 axis, thereby implicating a potential therapeutic intervention for human patients.
Subject(s)
Chemokine CCL20/metabolism , Colitis, Ulcerative/pathology , Colorectal Neoplasms/immunology , Interleukin-6/metabolism , Obesity/immunology , Receptors, CCR6/metabolism , Animals , Cell Transformation, Neoplastic/immunology , Cell Transformation, Neoplastic/pathology , Chemokine CCL20/immunology , Chemotaxis/immunology , Colitis, Ulcerative/chemically induced , Colitis, Ulcerative/immunology , Colon/drug effects , Colon/immunology , Colon/pathology , Colorectal Neoplasms/pathology , Diet, High-Fat/adverse effects , Disease Models, Animal , Disease Progression , Female , Humans , Interleukin-6 Receptor alpha Subunit/genetics , Interleukin-6 Receptor alpha Subunit/metabolism , Intestinal Mucosa/drug effects , Intestinal Mucosa/immunology , Intestinal Mucosa/pathology , Lymphocytes/immunology , Lymphocytes/metabolism , Macrophages/immunology , Macrophages/metabolism , Mice , Mice, Knockout , Obesity/etiology , Receptors, CCR6/genetics , Signal Transduction/immunology , Tumor Microenvironment/immunologyABSTRACT
The genome of the human pathogen Corynebacterium resistens DSM 45100 is equipped with a histidine utilization (hut) gene cluster encoding a four-step pathway for the catabolism of l-histidine and a transcriptional regulator of the IclR superfamily, now named HutR. The utilization of l-histidine might be relevant for the growth of C. resistens in its natural habitat, probably the histidine-rich inguinal and perineal areas of the human body. The ability of C. resistens to utilize l-histidine as a sole source of nitrogen was demonstrated by growth assays in synthetic minimal media. Reverse transcriptase PCRs revealed enhanced transcript levels of the hut genes in C. resistens cells grown in the presence of l-histidine. Promoter-probe assays showed that the hut genes are organized in three transcription units: hutHUI, hutR, and hutG. The respective transcriptional start sites were mapped by 5' RACE-PCR to detected putative promoter regions. DNA band shift assays with purified HutR protein identified the 14-bp DNA sequence TCTGwwATwCCAGA located upstream of the mapped promoters. This DNA motif includes a 4-bp terminal palindrome, which turned out to be essential for HutR binding in vitro. These data add a new physiological function to the large IclR family of transcriptional regulators.